- Trials with a EudraCT protocol (104)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
104 result(s) found for: Dysphagia.
Displaying page 1 of 6.
EudraCT Number: 2004-003116-33 | Sponsor Protocol Number: 20030185 | Start Date*: 2005-04-11 | |||||||||||
Sponsor Name:Swedish Orphan Biovitrum (Sobi) AB (publ) | |||||||||||||
Full Title: A Phase 2 Study to Evaluate the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) in the Reduction of Dysphagia in Patients Receiving Concurrent Chemoradiotherapy fo... | |||||||||||||
Medical condition: Dysphasia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001502-26 | Sponsor Protocol Number: TRIAMRAD001 | Start Date*: 2012-09-07 | ||||||||||||||||
Sponsor Name:Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E. | ||||||||||||||||||
Full Title: Intralesional steroid injection in radiation-induced esophageal strictures | ||||||||||||||||||
Medical condition: Radiation induced esophageal strictures | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: PT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005208-14 | Sponsor Protocol Number: R17548 | Start Date*: 2012-06-18 | |||||||||||
Sponsor Name:Norfolk and Norwich University Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Innovative Gel Aid for Administering Tablets to Stroke and Other Dysphagic Patients | |||||||||||||
Medical condition: Healthy volunteers will be used in the study however the gel device being investigated has been developed with the aim of aiding swallowing in stroke and other dysphagic patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000603-16 | Sponsor Protocol Number: HYPOXIC | Start Date*: 2013-09-12 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: HYPerbaric OXygen therapy for benign anastomotIC esophageal strictures: a pilot study | ||
Medical condition: Patients with benign recurrent and refractory esophageal anastomotic strictures. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003755-12 | Sponsor Protocol Number: | Start Date*: 2006-10-24 |
Sponsor Name:Hull & East Yorkshire NHS Trust | ||
Full Title: A Randomised Phase III Study in Advanced Oesophageal Cancer to compare Quality of Life and Palliation of Dysphagia in Patients Treated with Radiotherapy versus Chemo-radiotherapy. | ||
Medical condition: Advanced oesophageal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005842-39 | Sponsor Protocol Number: 226361 | Start Date*: 2013-12-20 |
Sponsor Name:NU-sjukvården, Norra Älvsborgs Länssjukhus | ||
Full Title: Treatment of eosinophilic esophagitis with mometason furoat aerosol: a randomised, placebo-controled phase II study for evaluation of treatment effect on group level including symtom questionnaires | ||
Medical condition: Eosinphilic Esophagitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004723-17 | Sponsor Protocol Number: UZBSK001 | Start Date*: 2021-02-26 |
Sponsor Name:UZ Brussel | ||
Full Title: Clinical usefulness and influence on oesophageal motility of pyridostigmine for dysphagia in systemic sclerosis. | ||
Medical condition: Dysphagia by patients suffering from systemic sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005246-59 | Sponsor Protocol Number: EO1115 | Start Date*: 2016-03-23 | |||||||||||
Sponsor Name:Michael Patrick Achiam | |||||||||||||
Full Title: Endoscopic electroporation in esophageal cancer | |||||||||||||
Medical condition: Esophageal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002210-23 | Sponsor Protocol Number: 1.4botox | Start Date*: 2014-10-14 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Can local intramuscular botulinum toxin improve dysphagia in patients with myopathic dysphagia and constriction of the cricoid muscle? | |||||||||||||
Medical condition: Oculopharyngesl muscle dystrophy, inclusion body myositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021390-36 | Sponsor Protocol Number: buspar2010 | Start Date*: 2010-09-07 |
Sponsor Name:uzleuven | ||
Full Title: The Effect of Acute Intake of Oral Buspirone Hydrochloride on Esophageal Motility, Bolus Transit and Symptoms of Dysphagia, in Patients with Ineffective Esophageal Motility: A Pilot, Open-label, Si... | ||
Medical condition: Ineffective Esophageal Motility | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004336-16 | Sponsor Protocol Number: CC-93538-EE-001 | Start Date*: 2021-09-29 | |||||||||||
Sponsor Name:Celgene International II Sàrl | |||||||||||||
Full Title: A Phase 3, Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and Maintenance Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Subject... | |||||||||||||
Medical condition: EOSINOPHILIC ESOPHAGITIS | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) AT (Ongoing) PT (Ongoing) BE (Ongoing) PL (Ongoing) IT (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024425-20 | Sponsor Protocol Number: Esperanz-002 | Start Date*: 2011-03-14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Leiden University Medical Centre | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Phase III Randomized Double-blind Cross-over trial of Supersaturated Calcium-phosphate rinse (Caphosol®) versus NaCl 0.9% in the relief of Oral Mucositis in renal cell carcinoma, hepatocellular car... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: oral mucositis in renal cell carcinoma, hepatocellular carcinoma, and gastrointestinal stromal tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002187-26 | Sponsor Protocol Number: neostigmine2019 | Start Date*: 2019-08-28 |
Sponsor Name:KU Leuven - TARGID | ||
Full Title: A Prospective evaluation of the effect of a single dose of neostigmine in patients with patients with weak or absent esophageal peristalsis | ||
Medical condition: Patients with complaints of dysphagia and poor esophageal motility | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000094-91 | Sponsor Protocol Number: RC31/20/0518 | Start Date*: Information not available in EudraCT |
Sponsor Name:Toulouse University Hospital | ||
Full Title: EFFECT OF INTRANASAL OXYTOCIN ON DYSPHAGIA RELATED TO OROPHARYNGO-OESOPHAGEAL DYSMOTILITY TRANSIT IN CHILDREN AND ADOLESCENTS WITH PRADER-WILLI SYNDROME: A PHASE 3 STUDY (DYSMOT) | ||
Medical condition: Prader-Willi Syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-001786-12 | Sponsor Protocol Number: CDX0159-08 | Start Date*: 2023-03-31 | |||||||||||
Sponsor Name:Celldex Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults with Active Eosinophilic Esophagitis (The "EvolvE" Study) | |||||||||||||
Medical condition: Eosinophilic esophagitis (EoE) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) IT (Ongoing) PL (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002182-35 | Sponsor Protocol Number: buspirone2019 | Start Date*: 2019-09-10 |
Sponsor Name:KU Leuven - TARGID | ||
Full Title: The effect of oral buspirone hydrochloride on esophageal motility, bolus transit and symptoms of dysphagia, in patients with poor esophageal motility: A randomized, double-blind, placebo controlle... | ||
Medical condition: Patients with complaints of dysphagia and poor esophageal motility | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000082-16 | Sponsor Protocol Number: ACESO | Start Date*: 2021-01-21 | |||||||||||
Sponsor Name:EsoCap AG | |||||||||||||
Full Title: A randomized, placebo-controlled, double-blind trial evaluating the efficacy, tolerability and safety of ESO-101 in adult patients with active eosinophilic esophagitis | |||||||||||||
Medical condition: Active eosinophilic esophagitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NL (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002871-32 | Sponsor Protocol Number: D3255C00001 | Start Date*: 2020-02-05 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Investigate the Use of Benralizumab for Eosinophilic Esophagitis (MESSINA) | |||||||||||||
Medical condition: Eosinophilic Esophagitis (EoE) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) NL (Prematurely Ended) PL (Prematurely Ended) DE (Prematurely Ended) GB (GB - no longer in EU/EEA) FR (Ongoing) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001521-27 | Sponsor Protocol Number: SP-1011-003 | Start Date*: 2020-08-03 | |||||||||||
Sponsor Name:Adare Pharmaceuticals US, LP | |||||||||||||
Full Title: Fluticasone propionate Oral Dispersible Tablet Formulation in Eosinophilic Esophagitis: A Two-Part, Randomized, Double-blind, Placebo-Controlled Study of APT-1011 in Adult and Adolescent Subjects w... | |||||||||||||
Medical condition: Eosinophilic Esophagitis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003226-23 | Sponsor Protocol Number: APD334-206 | Start Date*: 2021-02-02 | |||||||||||
Sponsor Name:Arena Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects with Eosinophilic Esophagitis | |||||||||||||
Medical condition: Eosinophilic Esophagitis (EoE) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.